公开(公告)号：US20240132613A1

公开(公告)日：2024-04-25

申请号：US18531287

申请日：2023-12-06

Applicant: Genentech, Inc.

Inventor： Yu-Waye CHU ,  Iraj HOSSEINI ,  Saroja RAMANUJAN ,  Kapil GADKAR ,  Chi-Chung LI

IPC: C07K16/28 ,  A61K31/573 ,  A61K39/395

CPC classification number: C07K16/2887 ,  A61K31/573 ,  A61K39/3955 ,  C07K16/2809 ,  C07K16/2827 ,  C07K16/2866 ,  A61K2039/507

Abstract: The invention provides methods of dosing for the treatment of cancers, such as B cell proliferative disorders, with anti-cluster of differentiation 20 (CD20)/anti-cluster of differentiation 3 (CD3) bispecific antibodies.

公开(公告)号：US20180134798A1

公开(公告)日：2018-05-17

申请号：US15813657

申请日：2017-11-15

Applicant: Genentech, Inc.

Inventor： Yu-Waye CHU ,  Iraj HOSSEINI ,  Saroja RAMANUJAN ,  Kapil GADKAR ,  Chi-Chung LI

IPC: C07K16/28 ,  A61K31/573 ,  A61K39/395

CPC classification number: C07K16/2887 ,  A61K31/573 ,  A61K39/3955 ,  A61K2039/507 ,  A61K2039/54 ,  A61K2039/545 ,  C07K16/2809 ,  C07K16/2827 ,  C07K16/2866 ,  C07K2317/24 ,  C07K2317/31 ,  C07K2317/41

Abstract: The invention provides methods of dosing for the treatment of cancers, such as B cell proliferative disorders, with anti-cluster of differentiation 20 (CD20)/anti-cluster of differentiation 3 (CD3) bispecific antibodies.